Recruiting nowPhase 3
A Study of BGM0504 in Early T2DM With Obesity
Updated 2026-08-04 · NCT07743983See eligibility →
Sponsor
Clinical trials sponsored by BrightGene Bio-Medical Technology Co., Ltd.
Active studies whose public registry record names BrightGene Bio-Medical Technology Co., Ltd. as lead sponsor.
10active studies
9recruiting now
3countries represented
4largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowPhase 1
Bioequivalence Study of BGM0504 Injection
Updated 2026-02-03 · NCT07382908See eligibility →
Updated 2025-12-19 · NCT07294235See eligibility →
Updated 2025-11-20 · NCT07239973See eligibility →
Updated 2025-11-06 · NCT07224399See eligibility →
Recruiting nowPhase 3
A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
Updated 2025-10-28 · NCT07064486See eligibility →
Recruiting nowPhase 2
A Study of BGM0504 in Participants With Obesity
Updated 2025-10-28 · NCT06911203See eligibility →
Updated 2025-09-19 · NCT07166081See eligibility →
Recruiting nowPhase 3
A Study of BGM0504 in Participants with Type 2 Diabetes
Updated 2025-02-07 · NCT06716216See eligibility →
Updated 2026-06-22 · NCT07658560See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.